Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention

Fig. 1

The 30-day (a) and 3-year (b) cumulative occurrence of MACEs for curves in NSTEMI patients undergoing PCI stratified according to diabetic status and admission plasma glucose (APG). Patients in Group 2 had higher cumulative occurrence rates of 30-day and 3-year MACEs. Patients in Group 4 had higher cumulative occurrence rates of 30-day and 3-year MACEs. Groups 1 and 2: without DM, APG <144 or ≥ 144 mg/dl. Groups 3 and 4: with DM, APG < or ≥ 180 mg/dl

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us